CYP2D6 Chromosome 22

Cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)
215 variants 215 Drug Response

Upload your DNA to see your personal genotypes for variants in CYP2D6.

What This Gene Does
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Gene Info
Gene Group
Cytochrome P450 family 2
Locus Type
gene with protein product
Location
22q13.2
Ensembl
ENSG00000100197
Associated Conditions (13)
Debrisoquine
poor metabolism of
Deutetrabenazine response
Tamoxifen response
Tramadol response
Familial cancer of breast
Uveal melanoma
Malignant lymphoma
large B-cell
diffuse
Melanoma
Uterine carcinosarcoma
Acute myeloid leukemia
Key Variants
Drug Interactions (5)
Codeine metabolism strong
CYP2D6*4 — poor metaboliser, reduced codeine-to-morphine conversion
Tamoxifen efficacy strong
CYP2D6*4 — reduced conversion to active metabolite endoxifen
Tramadol metabolism strong
CYP2D6*4 — reduced efficacy of tramadol
Fluoxetine metabolism moderate
CYP2D6*4 — may need dose adjustment
Paroxetine metabolism moderate
CYP2D6*4 — substrate of CYP2D6
All Variants (215)
RSID Category Clinical Significance Conditions
RS770112850 Drug Response drug response Tramadol response, Tramadol response
RS771000444 Drug Response drug response Tramadol response, Tramadol response
RS771263462 Drug Response drug response Tramadol response, Tramadol response
RS773065145 Drug Response drug response Tramadol response, Tramadol response
RS773148044 Drug Response drug response Tramadol response, Tramadol response
RS775131598 Drug Response drug response Tramadol response, Tramadol response
RS77913725 Drug Response drug response Tramadol response, Tramadol response
RS78762568 Drug Response drug response Tramadol response, Tramadol response
RS915922776 Drug Response drug response Tramadol response, Tramadol response
RS959768306 Drug Response drug response Tramadol response, Tramadol response
RS971209042 Drug Response drug response Tramadol response, Tramadol response
RS975260299 Drug Response drug response Tramadol response, Tramadol response
RS1065852 Drug Response Likely benign; drug response; other Debrisoquine, poor metabolism of, Tramadol response
RS28371725 Drug Response Likely benign; drug response; other Tramadol response, Tamoxifen response, Deutetrabenazine response
RS3892097 Drug Response Likely benign; drug response; other Debrisoquine, poor metabolism of, Tamoxifen response
« Prev 1 2 3 4 5
Sign Up to Analyze Your DNA Log In